128 related articles for article (PubMed ID: 23922608)
21. Survival by histologic subtype in stage IV nonsmall cell lung cancer based on data from the Surveillance, Epidemiology and End Results Program.
Cetin K; Ettinger DS; Hei YJ; O'Malley CD
Clin Epidemiol; 2011; 3():139-48. PubMed ID: 21607015
[TBL] [Abstract][Full Text] [Related]
22. Extent of surgery and survival in early lung carcinoma: implications for overdiagnosis in stage IA nonsmall cell lung carcinoma.
Sugarbaker DJ; Strauss GM
Cancer; 2000 Dec; 89(11 Suppl):2432-7. PubMed ID: 11147621
[TBL] [Abstract][Full Text] [Related]
23. Definitive radiotherapy for stage I nonsmall cell lung cancer: a population-based study of survival.
Milano MT; Zhang H; Usuki KY; Singh DP; Chen Y
Cancer; 2012 Nov; 118(22):5572-9. PubMed ID: 22544655
[TBL] [Abstract][Full Text] [Related]
24. CXCR4 expression in lung carcinogenesis: Evaluating gender-specific differences in survival outcomes based on CXCR4 expression in early stage non-small cell lung cancer patients.
Fung AS; Kopciuk K; Dean ML; D'Silva A; Otsuka S; Klimowicz A; Hao D; Morris D; Bebb DG
PLoS One; 2021; 16(1):e0241240. PubMed ID: 33507926
[TBL] [Abstract][Full Text] [Related]
25. Influence of tumor volume on survival in patients irradiated for non-small-cell lung cancer.
Etiz D; Marks LB; Zhou SM; Bentel GC; Clough R; Hernando ML; Lind PA
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):835-46. PubMed ID: 12095548
[TBL] [Abstract][Full Text] [Related]
26. Elevated expression of G3BP1 associates with YB1 and p-AKT and predicts poor prognosis in nonsmall cell lung cancer patients after surgical resection.
Zheng H; Zhan Y; Zhang Y; Liu S; Lu J; Yang Y; Wen Q; Fan S
Cancer Med; 2019 Nov; 8(16):6894-6903. PubMed ID: 31560169
[TBL] [Abstract][Full Text] [Related]
27. Impact of unfavorable factors on outcomes among inoperable stage II-IV Nonsmall cell lung cancer patients treated with proton therapy.
Zhu HJ; Nichols RC; Henderson RH; Morris CG; Flampouri S; Pham DC; Klassen CL; Seeram V; Cury JD; Jones L; McGee L; Hoppe BS
Acta Oncol; 2019 Mar; 58(3):313-319. PubMed ID: 30656994
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological features and outcomes in advanced nonsmall cell lung cancer with tailored therapy.
Bala S; Gundeti S; Linga VG; Maddali LS; Digumarti RR; Uppin SG
Indian J Med Paediatr Oncol; 2016; 37(4):242-250. PubMed ID: 28144090
[TBL] [Abstract][Full Text] [Related]
29. Stage IB nonsmall cell lung cancers: are they all the same?
Jones DR; Daniel TM; Denlinger CE; Rundall BK; Smolkin ME; Wick MR
Ann Thorac Surg; 2006 Jun; 81(6):1958-62; discussion 1962. PubMed ID: 16731113
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma.
Arinaga M; Noguchi T; Takeno S; Chujo M; Miura T; Uchida Y
Cancer; 2003 Jan; 97(2):457-64. PubMed ID: 12518370
[TBL] [Abstract][Full Text] [Related]
31. Age, tumor size, type of surgery, and gender predict survival in early stage (stage I and II) non-small cell lung cancer after surgical resection.
Agarwal M; Brahmanday G; Chmielewski GW; Welsh RJ; Ravikrishnan KP
Lung Cancer; 2010 Jun; 68(3):398-402. PubMed ID: 19762109
[TBL] [Abstract][Full Text] [Related]
32. Use of adjuvant chemotherapy for nonsmall cell lung cancer: Is advanced age a prognostic factor?
Batum O; Anar C; Özdoğan Y; Ermin S; Yılmaz U
Indian J Cancer; 2018; 55(3):282-287. PubMed ID: 30693895
[TBL] [Abstract][Full Text] [Related]
33. Improved outcomes associated with higher surgery rates for older patients with early stage nonsmall cell lung cancer.
Gray SW; Landrum MB; Lamont EB; McNeil BJ; Jaklitsch MT; Keating NL
Cancer; 2012 Mar; 118(5):1404-11. PubMed ID: 21800285
[TBL] [Abstract][Full Text] [Related]
34. Treatment of clinical T4 stage superior sulcus non-small cell lung cancer: a propensity-matched analysis of the surveillance, epidemiology, and end results database.
Wen J; Liu D; Chen D; Chen J; Xu X; Chen C; Zhang F; Duan S; Zhu R; Fan M; Chen Y
Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30647107
[No Abstract] [Full Text] [Related]
35. Prognostic value of quantitative PET/CT in patients with a nonsmall cell lung cancer and another primary cancer.
Zhu X; Liao C; Penney BC; Li F; Ferguson MK; Simon CA; Wu T; Liu H; Pu Y
Nucl Med Commun; 2017 Feb; 38(2):185-192. PubMed ID: 27922540
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors in resected pathological N1-stage II nonsmall cell lung cancer.
Liu CY; Hung JJ; Wang BY; Hsu WH; Wu YC
Eur Respir J; 2013 Mar; 41(3):649-55. PubMed ID: 22835612
[TBL] [Abstract][Full Text] [Related]
37. High preoperative and postoperative levels of carcinoembryonic antigen and CYFRA 21-1 indicate poor prognosis in patients with pathological Stage I nonsmall cell lung cancer.
Duan X; Cui Y; Li H; Shi G; Wu B; Liu M; Chang D; Wang T; Kong Y
Indian J Cancer; 2015 Dec; 52 Suppl 3():E158-63. PubMed ID: 27453414
[TBL] [Abstract][Full Text] [Related]
38. [Prognostic analysis of stage III-IV non-small cell lung cancer patients treated by traditional chinese medicine].
Zhou DH; Lin LZ; Zhou YQ; Luo RC; Liu KF; Jia YJ; Chen JY; Niu XW; Su BR; Lu J; Wang ST
Ai Zheng; 2005 Oct; 24(10):1252-6. PubMed ID: 16219143
[TBL] [Abstract][Full Text] [Related]
39. Nonsmall cell lung cancer: evaluation of 737 consecutive patients in a single institution.
Younes RN; Deutsch F; Badra C; Gross J; Haddad F; Deheinzelin D
Rev Hosp Clin Fac Med Sao Paulo; 2004 Jun; 59(3):119-27. PubMed ID: 15286831
[TBL] [Abstract][Full Text] [Related]
40. Result of the 6-min walk test is an independent prognostic factor of surgically treated non-small-cell lung cancer.
Marjanski T; Badocha M; Wnuk D; Dziedzic R; Ostrowski M; Sawicka W; Rzyman W
Interact Cardiovasc Thorac Surg; 2019 Mar; 28(3):368-374. PubMed ID: 30203070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
